Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Shares Slide on Lackluster Q4 Revenue, Earnings

NEW YORK, Feb. 17 (GenomeWeb News) - Shares of Beckman Coulter were down $3.36, or 5.59 percent, at $56.80 in mid-afternoon trading after the company reported a 5-percent drop in fourth-quarter sales.


As GenomeWeb News reported this morning, sales fell by 5.4 percent in the fourth quarter to $655.5 million from $693 million during the year-ago period.


Fourth-quarter consumable sales were up 12 percent, with acquisitions contributing to 3.9 percent of that growth.


Net income for the period decreased 70 percent to $17.8 million from $59.8 million during the fourth quarter of 2004.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.